ACTINOGEN MEDICAL
Actinogen Medical is biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive. Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. Our management team and scientific advisory board includes world-renowned Alzheimer’s disease and dementia researchers, and industry specialists i... n drug design and clinical trial management. Actinogen Medical’s drug candidate Xanamem has been specifically designed to block the production of cortisol in the brain. Drugs that reduce cortisol in the brain offer a promising new approach to slowing, or even preventing, the cognitive decline associated with Alzheimer’s disease. Actinogen Medical is currently conducting XanADu, an international multi-site Phase II efficacy and safety trial of Xanamem in patients with mild Alzheimer’s disease. Recruitment and treatment of patients started in 2017, with results expected in early 2019.
ACTINOGEN MEDICAL
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.actinogen.com.au
Total Employee:
1+
Status:
Active
Contact:
+61 2 8964 7401
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Gordagen Pharmaceuticals
Gordagen Pharmaceuticals is a private Australian company, developing novel treatments for hyperlipidaemia, diabetes, inflammatory diseases
IntelliHep
IntelliHep is a spin-out company developing novel drugs for Alzheimers disease and cancer.
Ixtlan Bioscience
Ixtlan Bioscience focused on developing psilocybin-based treatment for Alzheimer's Disease and Brain Pathologies.
NVH Medicinal
NVH Medicinal is a biotechnology company based on the treatment of pathologies linked to a collagen deficiency.
Sitari Pharmaceuticals
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-11-01 | Corticrine | Corticrine acquired by Actinogen Medical | N/A |
Investors List
KTM Ventures Innovation Fund
KTM Ventures Innovation Fund investment in Venture Round - Actinogen Medical
Official Site Inspections
http://www.actinogen.com.au Semrush global rank: 3.24 M Semrush visits lastest month: 4.49 K
- Host name: au1.wpxhosting.com
- IP address: 103.25.59.18
- Location: Sydney Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
More informations about "Actinogen Medical"
Actinogen – About Us
Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological diseases associated with dysregulated brain cortisol. There is a strong …See details»
Actinogen Medical - Crunchbase Company Profile
Actinogen Medical is biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive. Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s …See details»
Investor Centre - Actinogen
Welcome to the Actinogen Investor Centre. Here, shareholders and prospective investors can find all the essential information for investors ranging from the current share price to the latest announcements to the Australian Securities …See details»
Actinogen Medical - Edison Group
Nov 22, 2024 Actinogen’s Xanamem is a once-daily oral selective 11beta-HSD1 inhibitor, designed to cross the blood-brain barrier and target excess brain cortisol, which has been associated with cognitive impairment in chronic brain …See details»
Actinogen Medical Company Profile - Office Locations ... - Craft
Jul 12, 2024 Actinogen Medical is a biotech company providing treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative and metabolic diseases. …See details»
Actinogen Medical - LinkedIn
Actinogen Medical | 3,209 followers on LinkedIn. A biotech company developing novel therapies for Alzheimer’s disease and other potential neurological diseases (ASX:ACW) | Actinogen …See details»
Actinogen Medical Ltd, ACW:ASX profile - FT.com - Financial Times
Nov 22, 2024 Actinogen Medical Ltd Select House SE 901 L 9, 109 Pitt Street SYDNEY 2000 Australia AUS; Phone +61 28964-7401; Fax +61 28964-7588; Website https://actinogen.com.au/See details»
Actinogen Medical - Overview, News & Similar companies
Apr 22, 2024 Who is Actinogen Medical. Actinogen Medical Limited, a biotechnology company, develops therapies for cognitive impairment associated with chronic neurological diseases in …See details»
Actinogen – Corporate Governance
The latest Corporate Governance Statement was approved by the Board and is current as at 25 August 2022. The Board of Actinogen Medical Limited currently consists of four Directors. All …See details»
ACW News, Analysis, Announcements & Results | Actinogen …
6 days ago Actinogen Medical raises $5.2m for Alzheimer's treatment Alzheimer's disease is the second biggest killer of Australians, but investors have just bet $5.3 million that an ASX-listed …See details»
Alzheimer’s drug developer Actinogen rattles the tin - Financial …
Sep 17, 2024 ASX-listed Actinogen Medical is in front of potential investors seeking a $10 million equity injection to fund a trial for its Alzheimer's drug. Oct 13, 2020 Actinogen Medical raises …See details»
Actinogen Medical ASX:ACW Stock Report - Simply Wall St
5 days ago Research Actinogen Medical's (ASX:ACW) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. ...See details»
Actinogen Medical Limited - BIO International Convention | BIO
Jun 5, 2023 Actinogen is an ASX-listed, biotech company conducting Ph 2 trials of an oral, brain-penetrant small molecule for Alzheimer’s Disease (AD) and cognitive impairment …See details»
Contact Us - Actinogen
[email protected]. Company Secretary. Peter Webse. Address: Level 2, 50 Kings Park Road West Perth WA 6005 PO Box 271 West Perth WA 6872. Phone: Phone: +61 8 6377 …See details»
Actinogen Medical Ltd (ASX: ACW) Share Price and News - The …
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on …See details»
Alzheimer’s drug company Actinogen raising up to $15m
Nov 23, 2021 Actinogen is creating a drug to target cognitive impairment in Alzheimers. Alamy Priced at 13.5¢ per share, it comes at a 15.6 per cent discount to the company’s last closing …See details»
Our Team - Actinogen
Mar 1, 2017 B.Bus, FGIA, FCPA, MAICD Appointed 10 October 2013. Mr Webse joined Actinogen in 2013 and has over 27 years of company secretarial experience. He is the …See details»
Health Check: Actinogen powers ahead with key Alzheimer’s …
Nov 14, 2024 Actinogen Medical (ASX:ACW) reports that its well-anticipated Alzheimer’s disease clinical trial is on track, with an interim analysis expected by mid next year. At the …See details»
Actinogen – Corporate Presentations
May 6, 2024 Webcast Video Recording: Actinogen Clinical Trials Science Forum 2024 – Pipeline in a Pill. 06 May 2024. Video interview: [2:49 mins] Market Link interview with ACW CEO, …See details»